Cerenion
Cerenion is a medical device company specializing in AI-assisted EEG monitoring solutions for acute healthcare. Their flagship product, C-Trend, is a CE-marked software library that transforms complex EEG waveforms into clear quantitative parameters to aid real-time brain monitoring in intensive care settings. Integrated with Bittium's BrainStatus monitor, C-Trend enables continuous EEG monitoring using a single-use sub-hairline electrode, facilitating rapid and accessible brain monitoring for critically ill patients. The company emphasizes high quality, patient safety, and adherence to clinical guidelines, aiming to make continuous EEG monitoring routine in acute care. Cerenion is based in Finland and led by a team of founders with strong medical and technical expertise.
Cerenion
Cerenion is a medical device company specializing in AI-assisted EEG monitoring solutions for acute healthcare. Their flagship product, C-Trend, is a CE-marked software library that transforms complex EEG waveforms into clear quantitative parameters to aid real-time brain monitoring in intensive care settings. Integrated with Bittium's BrainStatus monitor, C-Trend enables continuous EEG monitoring using a single-use sub-hairline electrode, facilitating rapid and accessible brain monitoring for critically ill patients. The company emphasizes high quality, patient safety, and adherence to clinical guidelines, aiming to make continuous EEG monitoring routine in acute care. Cerenion is based in Finland and led by a team of founders with strong medical and technical expertise.
TL;DR
HQ: Oulu, Finland
Product: C-Trend — CE‑marked AI-assisted quantitative EEG (qEEG) software for acute/ICU monitoring
Founded: May 2017
Employees: 19
Funding: Series A; total funding reported $6,400,000 (last round 2022-04-12)
Founders: Dr. Jukka Kortelainen (CEO) and Dr. Eero Väyrynen (CTO) among cofounders
Company Overview
Problem Domain
Acute healthcare/ICU EEG monitoring and real-time brain function assessment
Founded
2017
Industry
Medical devices / Healthtech
Funding Track Record
Reported Series A round; public profiles list Springvest as lead investor.
Investor Signal
“Springvest lead investor on Series A”